S. KOREA APPROVES CELLTRION INC.’S COVID-19 ANTIBODY TREATMENT WITH CONDITIONS

Highlights –

• S. Korea approves Celltrion Inc.’s COVID-19 antibody treatment with conditions.
• The country’s drug safety agency has given conditional marketing authorization of CT-P59.
• Celltrion plans to conduct a global phase-three clinical trial in more than 10 countries.
• The antibody treatment candidate will be used for people at higher risk, mostly to peopl....
  Click here to read more

  ---

  Tags : SOUTH KOREA COVID-19, CELLTRION INC., COVID-19 ANTIBODY TREATMENT, SOUTH KOREA MINISTRY OF FOOD AND DRUG SAFETY, CELLTRION CT-P59, SOUTH KOREA COVID-19 TREATMENT, EMERGENCY USE AUTHORIZATION,

  ---

  SHARE THIS ARTICLE